Grey Street Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$28.7M Buy
36,907
+6,753
+22% +$4.81M 3.89% 1
2023
Q4
$17.6M Buy
30,154
+4,734
+19% +$2.76M 8.37% 1
2023
Q3
$13.7M Buy
25,420
+19,070
+300% +$9.83M 7.82% 1
2023
Q2
$2.98M Buy
+6,350
New +$2.66M 1.58% 16

Other funds holding LLY

Grey Street Capital's LLY Position: Q1 2024 in Review

Grey Street Capital increased its Eli Lilly (LLY) stake by 22% in Q1 2024, buying an estimated $4.81M and bringing the position to 36,907 shares worth $28.7M. The position accounts for 3.89% of the portfolio, ranked #1.

Grey Street Capital first reported a position in LLY in Q2 2023 and has held it in 4 quarters since. 3,463 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Grey Street Capital held 36,907 shares of Eli Lilly worth $28.7M as of Q1 2024.
  • Grey Street Capital bought 6,753 Eli Lilly shares in Q1 2024, an estimated $4.81M.
  • Eli Lilly made up 3.89% of Grey Street Capital's portfolio in Q1 2024, its #1 holding.
  • Grey Street Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 4 quarters since.
  • 3,463 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.